The Hyperpolarization-Activated Cyclic-Nucleotide-Gated Channel Blocker Ivabradine Does Not Prevent Arrhythmias in Catecholaminergic Polymorphic Ventricular Tachycardia
In conclusion, ivabradine does not exhibit anti-arrhythmic properties in CPVT, which indicates that this blocker cannot be used as a plausible treatment for CPVT ventricular arrhythmias.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Arrhythmia | Calcium | Cardiology | Drugs & Pharmacology | Heart | Reflex Sympathetic Dystrophy | Stem Cell Therapy | Stem Cells | Study | Ventricular Arrhythmia | Ventricular Tachycardia